CCR8 and neoplasm: CCR8 antagonism robustly suppressed liver cancer growth via switching the highly immunosuppressive TI-Tregs to less an immunosuppressive phenotype, leading to elevated anticancer immunity and a long-lasting tumor-suppressing effect.